Illumina (NASDAQ:ILMN), a company whose shares are moving quickly, is trading 1.2% higher to $54.94. The S&P is currently trading 0.3% higher to 1,558 and the Dow Jones Industrial Average is trading 0.2% higher to 14,586.
Illumina share prices have moved between a 52-week high of $79.40 and a 52-week low of $25.57 and are now trading 115% above that low price at $54.94 per share. The 200-day and 50-day moving averages have moved 0.47% higher and 0.38% higher over the past week, respectively.
There is potential upside of 0.2% for shares of Illumina based on a current price of $54.94 and an average consensus analyst price target of $55.07. The stock should discover initial support at its 50-day moving average (MA) of $51.56 and subsequent support at its 200-day MA of $48.01.
Illumina, Inc. develops, manufactures and markets integrated systems for the large scale analysis of genetic variation and biological function. The Company provides a comprehensive line of products and services that currently serve the sequencing, genotyping and gene expression markets for genomic research centers, pharmaceutical companies, academic institutions and biotechnology companies.